Market Research Logo

Gastrointestinal Drugs Market: Global Industry Analysis, Trends, Market Size & Forecasts to 2023

1. Preface
1.1 Report Description
1.2 Research Methods
1.3 Research Approaches
2. Executive Summary
3. Global Gastrointestinal Drugs Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunities
3.2.4 Challenges
3.3 Porter’s Five Forces Analysis
3.4 IGR – Growth Matrix Analysis
3.5 Competitive Landscape in the Gastrointestinal Drugs Market
4. Global Gastrointestinal Drugs Market : IGR Snapshots
4.1 Global Gastrointestinal Drugs Market key trends
4.2 Global Gastrointestinal Drugs Market by drug category
4.3 Global Gastrointestinal Drugs Market by route of administration
4.4 Global Gastrointestinal Drugs Market by Disease type
4.5 Global Gastrointestinal Drugs Market by Region
5. Global Gastrointestinal Drugs by Drug Category (USD Billion) 2017 – 2023
5.1 Acid Neutralizers
5.1.1 Antacids
5.1.2 H2 antagonists
5.1.3 Proton pump inhibitors
5.1.4 Helicobacter pylori eradication
5.2 Laxatives and Anti-diarrheal
5.3 Antiemetic and Antinauseants
5.4 Anti-Inflammatory
5.5 Biologics
5.6 Others
6. Global Gastrointestinal Drugs Market Analysis, by Route Of Administration (USD Billion) 2017 – 2023
6.1 Oral
6.2 Parenteral
6.3 Rectal
7. Global Gastrointestinal Drugs Market Analysis, by Disease Type (USD Billion) 2017 – 2023
7.1 GERD (Gastroesophageal Reflux Disorder)
7.2 Inflammatory Bowel Disease
7.3 Others
8. Global Gastrointestinal Drugs Market Analysis, by End User (USD Billion) 2017 – 2023
8.1 Hospital Pharmacies
8.2 Retail Pharmacies
8.3 Others
9. Global Gastrointestinal Drugs Market Analysis, by Region (USD Billion) 2017 – 2023
9.1 North America
9.1.1 North America gastrointestinal drugs market by drug category (USD Billion)
9.1.2 North America gastrointestinal drugs market by route of administration (USD Billion)
9.1.3 North America gastrointestinal drugs market by disease type (USD Billion)
9.1.4 North America gastrointestinal drugs market by end user (USD Billion)
9.2 Europe
9.2.1 Europe gastrointestinal drugs market by drug category (USD Billion)
9.2.2 Europe gastrointestinal drugs market by route of administration (USD Billion)
9.2.3 Europe gastrointestinal drugs market by disease type (USD Billion)
9.2.4 Europe gastrointestinal drugs market by end user (USD Billion)
9.3 Asia Pacific
9.3.1 APAC gastrointestinal drugs market by drug category (USD Billion)
9.3.2 APAC gastrointestinal drugs market by route of administration (USD Billion)
9.3.3 APAC gastrointestinal drugs market by disease type (USD Billion)
9.3.4 APAC gastrointestinal drugs market by end user (USD Billion)
9.4 RoW
9.4.1 ROW gastrointestinal drugs market by drug category (USD Billion)
9.4.2 ROW gastrointestinal drugs market by route of administration (USD Billion)
9.4.3 ROW gastrointestinal drugs market by disease type (USD Billion)
9.4.4 ROW gastrointestinal drugs market by end user (USD Billion)
10. Company Profiles
10.1 Abbott Laboratories
10.2 Allergan Plc
10.3 Bayer AG
10.4 AstraZeneca
10.5 Boehringer Ingelheim GmbH
10.6 GlaxoSmithKline Plc
10.7 Janssen Biotech Inc
10.8 Sanofi
10.9 Takeda Pharmaceutical
10.10 Valeant Pharmaceuticals Inc

Gastrointestinal Drugs Market: Global Industry Analysis, Trends, Market Size & Forecasts to 2023

The report on global Gastrointestinal Drugs market provides qualitative and quantitative analysis for the period of 2017 to 2023. The report predicts the global Gastrointestinal Drugs market to grow with a CAGR between 4.5 % and 5.0 % from 2017 to 2023. The global Gastrointestinal Drugs market was worth USD 46.5 Billion in 2016.The study on Gastrointestinal Drugs market covers the analysis of regions such as North America, Europe, Asia Pacific, and Rest of the World. Among the geographies North America dominated the world market and Asia Pacific anticipated growing at the highest CAGR over the forecast period.

The report on global Gastrointestinal Drugs market is a comprehensive study of demand, market size, forecasts, trends and factors affecting the global Gastrointestinal Drugs market. Moreover, the report is collective presentation of primary and secondary research findings. In addition, it provides deep insights on the factors that driving, restraining the global Gastrointestinal Drugs market. Porter’s five forces model in the report provides insights into the competitive rivalry in the global Gastrointestinal Drugs market over the period of 2017 – 2023. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research methodology
• Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

• Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources. The secondary sources of the data typically include
• Company reports and publications
• Government/institutional publications
• Trade and associations’ journals
• Databases such as WTO, OECD, and Worldbank, among others.
• Websites and publications by research agencies

Report Findings
1) Drivers
• Large amount of global population suffering from acute and chronic GI disorders.
• Increasing prevalence of gastrointestinal disease across the globe.
• Strong research and development activities in order to introduce new drugs
2) Restraints
• Unavailability of cure for GI related disorder.
3) Opportunities
• Technological advancements will offer massive growth opportunities
• Increasing geriatric population which are highly susceptible to gastrointestinal related disorder, as they have comparably less immunity.

Segments Covered
1) Global Gastrointestinal Drugs market
a. By drug catogery
• Antineutralizers
• Laxatives and Anti-diarrheal
• Antiemetic
• Anti-inflammatory

b. By Route of Administration
• Oral
• Parenteral
• Rectal

c. By Disease Type
• Gastroesophageal Reflux Disorder (GERD)
• Inflammatory Bowel Disease
• Others

d. By End User
• Hospital Pharmacies
• Retail Pharmacies
• Others

2) Global Gastrointestinal Drugs market by Region
a. North America
b. Europe
c. Asia Pacific
d. Row

Companies Profiled:
• Abbott Laboratories
• Allergan Plc
• Bayer AG
• AstraZeneca
• Boehringer Ingelheim GmbH
• GlaxoSmithKline Plc
• Janssen Biotech Inc
• Sanofi
• Takeda Pharmaceutical

Reasons to buy this report
1) Comprehensive analysis of global as well as regional markets of Gastrointestinal Drugs.
2) Complete coverage of all the product type and applications segments to analyse the trends, developments in Gastrointestinal Drugs market, and forecast of market size up to 2023.
3) Comprehensive analysis of the companies operating in Gastrointestinal Drugs market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4) Infinium Global Research- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;